Skip to main content
. 2024 Mar 21;13(3):285. doi: 10.3390/antibiotics13030285
AZT aztreonam
BL/BLI β-lactam/β-lactamase inhibitor
BCT Blue Carba Test
CDT combination disc testing
cIAI complicated intra-abdominal infection
CIM carbapenem inactivation method
CR-GNB carbapenem-resistant Gram-negative bacteria
C/T ceftolozane/tazobactam
cUTI complicated urinary tract infection
CZA ceftazidime/avibactam
eCIM EDTA-based CIM
ESBL extended-spectrum-β-lactamase
FICI fractional inhibitory concentration index
HAP hospital-acquired pneumonia
IMR imipenem/relebactam
IMP imipenemase
KPC Klebsiella pneumoniae carbapenemase
MBL metallo-β-lactamase
mCIM modified CIM test
MEV meropenem/vaborbactam
MIC minimum inhibitory concentration
NDM New Delhi metallo-β-lactamase
OXA oxacillinase
VAP ventilator-associated pneumonia
VIM Verona integron-mediated metallo-β-lactamase
XDR extensive drug-resistant